Neurotech International

Neurotech International P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Neurotech International (NTI.AX) as of Oct 17, 2026 is -4.30. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -2.01 — a change of 113.63% (lower).

P/CF

-4.30

YoY

113.63%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Neurotech International is 2026 -4.30 . P/CF (Price-to-Cash-Flow Ratio) of Neurotech International was 2025 -2.01 . It decreases by 113.63% lower compared to the previous year.

The Neurotech International P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
-7.14 AUD
Jan 1, 2020
-26.58 AUD
Jan 1, 2021
-7.83 AUD
Jan 1, 2022
-6.14 AUD
Jan 1, 2023
-2.87 AUD
Jan 1, 2024
-3.95 AUD
Jan 1, 2025
-2.01 AUD
Jan 1, 2026
-4.30 AUD
The Neurotech International P/CF history
YEARP/CFYoY
-4.30+113.63%
-2.01-49.08%
-3.95+37.47%
-2.87-53.22%
-6.14-21.61%
-7.83-70.52%
-26.58+272.43%
-7.14+18.98%
-6.00+3.15%
-5.81-74.82%
-23.10+8.33%
-21.32—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Neurotech International Stock analysis

What does Neurotech International do? Neurotech International Ltd is a health care company listed on 4 November 2016, headquartered in Nedlands, Australia. It researches, designs, and manufactures medical devices and solutions, focusing on neurological treatments, particularly for pediatric disorders. The firm commercializes Mente Autism, a portable electroencephalographic headband for home use that employs closed-loop neurofeedback to help relax children with autism spectrum disorder. Additionally, the company conducts clinical studies to evaluate the neuro-protective and anti-inflammatory properties of its NTI/Dolce cannabis strains. Its development program includes NTI164, which completed Phase I/II trials for autism treatment, aiming to improve engagement and relaxation in affected children. Neurotech International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurotech International stock

P/CF (Price-to-Cash-Flow Ratio) of Neurotech International is -4.30 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Neurotech International changed from -2.01 to -4.30, representing a 113.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Neurotech International since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Neurotech International with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Neurotech International

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Neurotech International